Botanix PharmaceuticalsBXPHF Days Inventory is 843.49 as of Dec. 2025, which is 46% below its 10-year median of 1,554.54. The stock has 7 warning signs investors should review. Among 635 Biotechnology companies, Botanix Pharmaceuticals ranks worse than 92.13% on this metric.
The historical rank and industry rank for Botanix Pharmaceuticals's Days Inventory or its related term are showing as below:
BXPHF'
s Days Inventory Range Over the Past 10 Years
Min: 1040.84 Med: 1554.54 Max: 1554.54
Current: 1040.84
During the past 13 years, Botanix Pharmaceuticals's highest Days Inventory was 1554.54. The lowest was 1040.84. And the median was 1554.54.
BXPHF's Days Inventory is ranked worse than 92.13% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs BXPHF: 1040.84
Botanix Pharmaceuticals's Days Inventory
declined
from Dec. 2024 (1,863.33) to Dec. 2025 (843.49).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Botanix Pharmaceuticals's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.22.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Botanix Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.67.
Botanix Pharmaceuticals (OTCPK:BXPHF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Botanix Pharmaceuticals's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Botanix Pharmaceuticals's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Botanix Pharmaceuticals Days Inventory Related Terms
Botanix Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BXPHF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Botanix Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Botanix Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Botanix Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Botanix Pharmaceuticals (BXPHF) has a Days Inventory of 843.49 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Botanix Pharmaceuticals and its competitors. This is 46% below median its historical median of 1,554.54. Over the past decade, Botanix Pharmaceuticals' Days Inventory has ranged from 1,040.84 to 1,554.54. According to the industry distribution chart, Botanix Pharmaceuticals ranks #585 out of 635 companies in the Biotechnology industry, placing it in the top 92.1%.
Is Botanix Pharmaceuticals' Days Inventory too high?
Botanix Pharmaceuticals' current Days Inventory of 843.49 is 46% below median its 10-year median of 1,554.54. Over the past 10 years, this metric has ranged from a low of 1,040.84 to a high of 1,554.54. The Biotechnology industry median Days Inventory is 183.23. Botanix Pharmaceuticals' value of 843.49 is 360.3% above this industry median. Based on the distribution chart, Botanix Pharmaceuticals ranks #585 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Botanix Pharmaceuticals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Botanix Pharmaceuticals ranks #585 out of 635 companies for Days Inventory. This places Botanix Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.23. Botanix Pharmaceuticals' value of 843.49 is 360.3% above this benchmark. Historically, Botanix Pharmaceuticals' own Days Inventory has ranged from 1,040.84 to 1,554.54 over the past decade. While the company's 10-year median is 1,554.54 vs. the industry median of 183.23, Botanix Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Botanix Pharmaceuticals's current Days Inventory of 843.49 is 360.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Botanix Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Botanix Pharmaceuticals's current Days Inventory is 843.49, which is 46% below median its own 10-year median of 1,554.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (BXPHF) has a current Days Inventory of 843.49. The current Days Inventory is 843.49, which is 46% below median its 10-year median of 1,554.54 and 360.3% above the Biotechnology industry median of 183.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Botanix Pharmaceuticals (BXPHF), the current Days Inventory is 843.49 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXPHF has been successfully added to your 